Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A need for new converting enzyme inhibitors?

Literature DB >> 2981597

A need for new converting enzyme inhibitors?

S G Ball, J I Robertson.

Abstract

Mesh：

Substances：

Year: 1985 PMID： 2981597 PMCID： PMC1417972 DOI： 10.1136/bmj.290.6463.180

Source DB: PubMed Journal: Br Med J (Clin Res Ed) ISSN： 0267-0623

× No keyword cloud information.

7 in total

1. Safety and efficacy of enalapril. Summing up the evidence.

Authors: C T Dollery
Journal: J Hypertens Suppl Date: 1983-10

2. Captopril and renal autoregulation.

Authors: W B Blythe
Journal: N Engl J Med Date: 1983-02-17 Impact factor: 91.245

3. Captopril: five years on.

Authors: G P Hodsman; J I Robertson
Journal: Br Med J (Clin Res Ed) Date: 1983-09-24

4. Captopril in heart failure. A double blind controlled trial.

Authors: J G Cleland; H J Dargie; G P Hodsman; S G Ball; J I Robertson; J J Morton; B W East; I Robertson; G D Murray; G Gillen
Journal: Br Heart J Date: 1984-11

5. Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man.

Authors: G P Hodsman; J R Zabludowski; C Zoccali; R Fraser; J J Morton; G D Murray; J I Robertson
Journal: Br J Clin Pharmacol Date: 1984-03 Impact factor: 4.335

Review 6. Enalapril worldwide experience.

Authors: R O Davies; J D Irvin; D K Kramsch; J F Walker; F Moncloa
Journal: Am J Med Date: 1984-08-20 Impact factor: 4.965

7. "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.

Authors: D McAreavey; L E Ramsey; L Latham; A D McLaren; A R Lorimer; J L Reid; J I Robertson; M P Robertson; R J Weir
Journal: Br Med J (Clin Res Ed) Date: 1984-01-14

7 in total

6 in total

6. A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man.

Authors: P J Manhem; S G Ball; J J Morton; G D Murray; B J Leckie; R Fraser; J I Robertson
Journal: Br J Clin Pharmacol Date: 1985-07 Impact factor: 4.335

6 in total

A need for new converting enzyme inhibitors?

1. Safety and efficacy of enalapril. Summing up the evidence.

2. Captopril and renal autoregulation.

3. Captopril: five years on.

4. Captopril in heart failure. A double blind controlled trial.

5. Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man.

Review 6. Enalapril worldwide experience.

7. "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.

1. Consequences of fluid loss in patients treated with ACE inhibitors.

Review 2. Newer ACE inhibitors. A look at the future.

Review 3. Angiotensin converting enzyme inhibitors and moderate hypertension.

4. Cough associated with captopril and enalapril.

5. Dose finding studies with imidapril--a new ACE inhibitor.

6. A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man.